nodes	percent_of_prediction	percent_of_DWPC	metapath
Phendimetrazine—Decreased appetite—Bortezomib—hematologic cancer	0.00115	0.00145	CcSEcCtD
Phendimetrazine—Headache—Procarbazine—hematologic cancer	0.00115	0.00145	CcSEcCtD
Phendimetrazine—Decreased appetite—Bleomycin—hematologic cancer	0.00114	0.00144	CcSEcCtD
Phendimetrazine—Anorexia—Thalidomide—hematologic cancer	0.00114	0.00144	CcSEcCtD
Phendimetrazine—Abdominal pain—Lenalidomide—hematologic cancer	0.00114	0.00144	CcSEcCtD
Phendimetrazine—Diarrhoea—Nilotinib—hematologic cancer	0.00114	0.00143	CcSEcCtD
Phendimetrazine—Constipation—Bortezomib—hematologic cancer	0.00113	0.00143	CcSEcCtD
Phendimetrazine—Diarrhoea—Imatinib—hematologic cancer	0.00113	0.00143	CcSEcCtD
Phendimetrazine—Headache—Bexarotene—hematologic cancer	0.00113	0.00142	CcSEcCtD
Phendimetrazine—Headache—Dasatinib—hematologic cancer	0.00113	0.00142	CcSEcCtD
Phendimetrazine—Decreased appetite—Vinorelbine—hematologic cancer	0.00112	0.00142	CcSEcCtD
Phendimetrazine—Headache—Fludarabine—hematologic cancer	0.00112	0.00142	CcSEcCtD
Phendimetrazine—Nausea—Busulfan—hematologic cancer	0.00112	0.00142	CcSEcCtD
Phendimetrazine—Tachycardia—Carmustine—hematologic cancer	0.00112	0.00141	CcSEcCtD
Phendimetrazine—Vision blurred—Cisplatin—hematologic cancer	0.00112	0.00141	CcSEcCtD
Phendimetrazine—Tremor—Cisplatin—hematologic cancer	0.00111	0.0014	CcSEcCtD
Phendimetrazine—Diarrhoea—Cladribine—hematologic cancer	0.00111	0.0014	CcSEcCtD
Phendimetrazine—Tachycardia—Alitretinoin—hematologic cancer	0.00111	0.0014	CcSEcCtD
Phendimetrazine—Constipation—Vinorelbine—hematologic cancer	0.00111	0.0014	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Alitretinoin—hematologic cancer	0.0011	0.00139	CcSEcCtD
Phendimetrazine—Dizziness—Nilotinib—hematologic cancer	0.0011	0.00139	CcSEcCtD
Phendimetrazine—Anorexia—Carmustine—hematologic cancer	0.00109	0.00138	CcSEcCtD
Phendimetrazine—Dizziness—Imatinib—hematologic cancer	0.00109	0.00138	CcSEcCtD
Phendimetrazine—Nausea—Procarbazine—hematologic cancer	0.00109	0.00138	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Ifosfamide—hematologic cancer	0.00109	0.00137	CcSEcCtD
Phendimetrazine—Anorexia—Alitretinoin—hematologic cancer	0.00108	0.00137	CcSEcCtD
Phendimetrazine—Insomnia—Thalidomide—hematologic cancer	0.00108	0.00136	CcSEcCtD
Phendimetrazine—Decreased appetite—Thiotepa—hematologic cancer	0.00107	0.00136	CcSEcCtD
Phendimetrazine—Dizziness—Cladribine—hematologic cancer	0.00107	0.00135	CcSEcCtD
Phendimetrazine—Anorexia—Ifosfamide—hematologic cancer	0.00107	0.00135	CcSEcCtD
Phendimetrazine—Nausea—Dasatinib—hematologic cancer	0.00107	0.00135	CcSEcCtD
Phendimetrazine—Nausea—Bexarotene—hematologic cancer	0.00107	0.00135	CcSEcCtD
Phendimetrazine—Nausea—Fludarabine—hematologic cancer	0.00107	0.00134	CcSEcCtD
Phendimetrazine—Diarrhoea—Vinblastine—hematologic cancer	0.00107	0.00134	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Vincristine—hematologic cancer	0.00106	0.00134	CcSEcCtD
Phendimetrazine—Constipation—Thiotepa—hematologic cancer	0.00106	0.00133	CcSEcCtD
Phendimetrazine—Abdominal pain—Bortezomib—hematologic cancer	0.00105	0.00132	CcSEcCtD
Phendimetrazine—Anorexia—Vincristine—hematologic cancer	0.00104	0.00132	CcSEcCtD
Phendimetrazine—Tachycardia—Mitoxantrone—hematologic cancer	0.00104	0.00131	CcSEcCtD
Phendimetrazine—Headache—Nilotinib—hematologic cancer	0.00104	0.00131	CcSEcCtD
Phendimetrazine—Decreased appetite—Thalidomide—hematologic cancer	0.00104	0.00131	CcSEcCtD
Phendimetrazine—Insomnia—Carmustine—hematologic cancer	0.00104	0.00131	CcSEcCtD
Phendimetrazine—Headache—Imatinib—hematologic cancer	0.00103	0.00131	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Irinotecan—hematologic cancer	0.00103	0.0013	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Mitoxantrone—hematologic cancer	0.00103	0.0013	CcSEcCtD
Phendimetrazine—Dizziness—Vinblastine—hematologic cancer	0.00103	0.0013	CcSEcCtD
Phendimetrazine—Insomnia—Alitretinoin—hematologic cancer	0.00103	0.0013	CcSEcCtD
Phendimetrazine—Abdominal pain—Vinorelbine—hematologic cancer	0.00102	0.00129	CcSEcCtD
Phendimetrazine—Constipation—Thalidomide—hematologic cancer	0.00102	0.00129	CcSEcCtD
Phendimetrazine—Anorexia—Mitoxantrone—hematologic cancer	0.00102	0.00128	CcSEcCtD
Phendimetrazine—Anorexia—Irinotecan—hematologic cancer	0.00102	0.00128	CcSEcCtD
Phendimetrazine—Headache—Cladribine—hematologic cancer	0.00102	0.00128	CcSEcCtD
Phendimetrazine—Diarrhoea—Melphalan—hematologic cancer	0.00101	0.00128	CcSEcCtD
Phendimetrazine—Vision blurred—Prednisolone—hematologic cancer	0.00101	0.00128	CcSEcCtD
Phendimetrazine—Nausea—Chlorambucil—hematologic cancer	0.00101	0.00127	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Gemcitabine—hematologic cancer	0.001	0.00127	CcSEcCtD
Phendimetrazine—Decreased appetite—Carmustine—hematologic cancer	0.000998	0.00126	CcSEcCtD
Phendimetrazine—Insomnia—Vincristine—hematologic cancer	0.000991	0.00125	CcSEcCtD
Phendimetrazine—Anorexia—Gemcitabine—hematologic cancer	0.000991	0.00125	CcSEcCtD
Phendimetrazine—Decreased appetite—Alitretinoin—hematologic cancer	0.000988	0.00125	CcSEcCtD
Phendimetrazine—Nausea—Nilotinib—hematologic cancer	0.000987	0.00125	CcSEcCtD
Phendimetrazine—Diarrhoea—Lenalidomide—hematologic cancer	0.000985	0.00124	CcSEcCtD
Phendimetrazine—Constipation—Carmustine—hematologic cancer	0.000981	0.00124	CcSEcCtD
Phendimetrazine—Nausea—Imatinib—hematologic cancer	0.000981	0.00124	CcSEcCtD
Phendimetrazine—Decreased appetite—Ifosfamide—hematologic cancer	0.000977	0.00123	CcSEcCtD
Phendimetrazine—Abdominal pain—Thiotepa—hematologic cancer	0.000977	0.00123	CcSEcCtD
Phendimetrazine—Headache—Vinblastine—hematologic cancer	0.000975	0.00123	CcSEcCtD
Phendimetrazine—Constipation—Alitretinoin—hematologic cancer	0.000972	0.00123	CcSEcCtD
Phendimetrazine—Diarrhoea—Hydroxyurea—hematologic cancer	0.000971	0.00123	CcSEcCtD
Phendimetrazine—Insomnia—Irinotecan—hematologic cancer	0.000965	0.00122	CcSEcCtD
Phendimetrazine—Nausea—Cladribine—hematologic cancer	0.000964	0.00122	CcSEcCtD
Phendimetrazine—Constipation—Ifosfamide—hematologic cancer	0.000961	0.00121	CcSEcCtD
Phendimetrazine—Decreased appetite—Vincristine—hematologic cancer	0.000952	0.0012	CcSEcCtD
Phendimetrazine—Dizziness—Lenalidomide—hematologic cancer	0.000952	0.0012	CcSEcCtD
Phendimetrazine—Tachycardia—Cisplatin—hematologic cancer	0.000945	0.00119	CcSEcCtD
Phendimetrazine—Abdominal pain—Thalidomide—hematologic cancer	0.000945	0.00119	CcSEcCtD
Phendimetrazine—Insomnia—Gemcitabine—hematologic cancer	0.00094	0.00119	CcSEcCtD
Phendimetrazine—Dizziness—Hydroxyurea—hematologic cancer	0.000939	0.00118	CcSEcCtD
Phendimetrazine—Constipation—Vincristine—hematologic cancer	0.000937	0.00118	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Cisplatin—hematologic cancer	0.000936	0.00118	CcSEcCtD
Phendimetrazine—Decreased appetite—Mitoxantrone—hematologic cancer	0.000927	0.00117	CcSEcCtD
Phendimetrazine—Decreased appetite—Irinotecan—hematologic cancer	0.000927	0.00117	CcSEcCtD
Phendimetrazine—Nausea—Vinblastine—hematologic cancer	0.000925	0.00117	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Epirubicin—hematologic cancer	0.000924	0.00117	CcSEcCtD
Phendimetrazine—Anorexia—Cisplatin—hematologic cancer	0.000923	0.00117	CcSEcCtD
Phendimetrazine—Constipation—Irinotecan—hematologic cancer	0.000912	0.00115	CcSEcCtD
Phendimetrazine—Constipation—Mitoxantrone—hematologic cancer	0.000912	0.00115	CcSEcCtD
Phendimetrazine—Abdominal pain—Carmustine—hematologic cancer	0.000907	0.00114	CcSEcCtD
Phendimetrazine—Diarrhoea—Bortezomib—hematologic cancer	0.000907	0.00114	CcSEcCtD
Phendimetrazine—Decreased appetite—Gemcitabine—hematologic cancer	0.000903	0.00114	CcSEcCtD
Phendimetrazine—Headache—Lenalidomide—hematologic cancer	0.000902	0.00114	CcSEcCtD
Phendimetrazine—Abdominal pain—Alitretinoin—hematologic cancer	0.000899	0.00113	CcSEcCtD
Phendimetrazine—Headache—Hydroxyurea—hematologic cancer	0.000889	0.00112	CcSEcCtD
Phendimetrazine—Constipation—Gemcitabine—hematologic cancer	0.000889	0.00112	CcSEcCtD
Phendimetrazine—Abdominal pain—Ifosfamide—hematologic cancer	0.000888	0.00112	CcSEcCtD
Phendimetrazine—Diarrhoea—Vinorelbine—hematologic cancer	0.000885	0.00112	CcSEcCtD
Phendimetrazine—Nausea—Melphalan—hematologic cancer	0.00088	0.00111	CcSEcCtD
Phendimetrazine—Dizziness—Bortezomib—hematologic cancer	0.000876	0.00111	CcSEcCtD
Phendimetrazine—Dysuria—Methotrexate—hematologic cancer	0.000874	0.0011	CcSEcCtD
Phendimetrazine—Tachycardia—Etoposide—hematologic cancer	0.000866	0.00109	CcSEcCtD
Phendimetrazine—Abdominal pain—Vincristine—hematologic cancer	0.000866	0.00109	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Etoposide—hematologic cancer	0.000858	0.00108	CcSEcCtD
Phendimetrazine—Dizziness—Vinorelbine—hematologic cancer	0.000855	0.00108	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Doxorubicin—hematologic cancer	0.000855	0.00108	CcSEcCtD
Phendimetrazine—Nausea—Lenalidomide—hematologic cancer	0.000855	0.00108	CcSEcCtD
Phendimetrazine—Tachycardia—Prednisolone—hematologic cancer	0.000854	0.00108	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Prednisolone—hematologic cancer	0.000846	0.00107	CcSEcCtD
Phendimetrazine—Anorexia—Etoposide—hematologic cancer	0.000846	0.00107	CcSEcCtD
Phendimetrazine—Diarrhoea—Thiotepa—hematologic cancer	0.000845	0.00107	CcSEcCtD
Phendimetrazine—Abdominal pain—Mitoxantrone—hematologic cancer	0.000843	0.00106	CcSEcCtD
Phendimetrazine—Abdominal pain—Irinotecan—hematologic cancer	0.000843	0.00106	CcSEcCtD
Phendimetrazine—Nausea—Hydroxyurea—hematologic cancer	0.000843	0.00106	CcSEcCtD
Phendimetrazine—Decreased appetite—Cisplatin—hematologic cancer	0.000842	0.00106	CcSEcCtD
Phendimetrazine—Flushing—Prednisone—hematologic cancer	0.000831	0.00105	CcSEcCtD
Phendimetrazine—Headache—Bortezomib—hematologic cancer	0.00083	0.00105	CcSEcCtD
Phendimetrazine—Dysuria—Epirubicin—hematologic cancer	0.000818	0.00103	CcSEcCtD
Phendimetrazine—Diarrhoea—Thalidomide—hematologic cancer	0.000818	0.00103	CcSEcCtD
Phendimetrazine—Dizziness—Thiotepa—hematologic cancer	0.000817	0.00103	CcSEcCtD
Phendimetrazine—Headache—Vinorelbine—hematologic cancer	0.00081	0.00102	CcSEcCtD
Phendimetrazine—Pollakiuria—Epirubicin—hematologic cancer	0.000808	0.00102	CcSEcCtD
Phendimetrazine—Sweating—Methotrexate—hematologic cancer	0.000799	0.00101	CcSEcCtD
Phendimetrazine—Insomnia—Prednisolone—hematologic cancer	0.000792	0.000999	CcSEcCtD
Phendimetrazine—Dizziness—Thalidomide—hematologic cancer	0.00079	0.000997	CcSEcCtD
Phendimetrazine—Nausea—Bortezomib—hematologic cancer	0.000787	0.000993	CcSEcCtD
Phendimetrazine—Tachycardia—Triamcinolone—hematologic cancer	0.000786	0.000991	CcSEcCtD
Phendimetrazine—Diarrhoea—Carmustine—hematologic cancer	0.000785	0.000991	CcSEcCtD
Phendimetrazine—Nausea—Bleomycin—hematologic cancer	0.000781	0.000986	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.000778	0.000982	CcSEcCtD
Phendimetrazine—Diarrhoea—Alitretinoin—hematologic cancer	0.000778	0.000982	CcSEcCtD
Phendimetrazine—Headache—Thiotepa—hematologic cancer	0.000774	0.000977	CcSEcCtD
Phendimetrazine—Decreased appetite—Etoposide—hematologic cancer	0.000771	0.000974	CcSEcCtD
Phendimetrazine—Diarrhoea—Ifosfamide—hematologic cancer	0.000769	0.00097	CcSEcCtD
Phendimetrazine—Nausea—Vinorelbine—hematologic cancer	0.000768	0.00097	CcSEcCtD
Phendimetrazine—Dizziness—Carmustine—hematologic cancer	0.000759	0.000958	CcSEcCtD
Phendimetrazine—Constipation—Etoposide—hematologic cancer	0.000759	0.000958	CcSEcCtD
Phendimetrazine—Dysuria—Doxorubicin—hematologic cancer	0.000757	0.000955	CcSEcCtD
Phendimetrazine—Dizziness—Alitretinoin—hematologic cancer	0.000752	0.000949	CcSEcCtD
Phendimetrazine—Diarrhoea—Vincristine—hematologic cancer	0.00075	0.000946	CcSEcCtD
Phendimetrazine—Headache—Thalidomide—hematologic cancer	0.000749	0.000945	CcSEcCtD
Phendimetrazine—Sweating—Epirubicin—hematologic cancer	0.000748	0.000944	CcSEcCtD
Phendimetrazine—Pollakiuria—Doxorubicin—hematologic cancer	0.000748	0.000944	CcSEcCtD
Phendimetrazine—Dizziness—Ifosfamide—hematologic cancer	0.000743	0.000938	CcSEcCtD
Phendimetrazine—Vision blurred—Prednisone—hematologic cancer	0.000734	0.000927	CcSEcCtD
Phendimetrazine—Nausea—Thiotepa—hematologic cancer	0.000734	0.000926	CcSEcCtD
Phendimetrazine—Diarrhoea—Irinotecan—hematologic cancer	0.00073	0.000921	CcSEcCtD
Phendimetrazine—Diarrhoea—Mitoxantrone—hematologic cancer	0.00073	0.000921	CcSEcCtD
Phendimetrazine—Insomnia—Triamcinolone—hematologic cancer	0.000728	0.000919	CcSEcCtD
Phendimetrazine—Dizziness—Vincristine—hematologic cancer	0.000724	0.000914	CcSEcCtD
Phendimetrazine—Headache—Carmustine—hematologic cancer	0.000719	0.000907	CcSEcCtD
Phendimetrazine—Agitation—Prednisone—hematologic cancer	0.000716	0.000904	CcSEcCtD
Phendimetrazine—Tachycardia—Dexamethasone—hematologic cancer	0.000713	0.0009	CcSEcCtD
Phendimetrazine—Tachycardia—Betamethasone—hematologic cancer	0.000713	0.0009	CcSEcCtD
Phendimetrazine—Headache—Alitretinoin—hematologic cancer	0.000712	0.000899	CcSEcCtD
Phendimetrazine—Diarrhoea—Gemcitabine—hematologic cancer	0.000711	0.000897	CcSEcCtD
Phendimetrazine—Nausea—Thalidomide—hematologic cancer	0.00071	0.000896	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000706	0.000891	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000706	0.000891	CcSEcCtD
Phendimetrazine—Dizziness—Irinotecan—hematologic cancer	0.000706	0.00089	CcSEcCtD
Phendimetrazine—Abdominal pain—Etoposide—hematologic cancer	0.000702	0.000885	CcSEcCtD
Phendimetrazine—Anorexia—Dexamethasone—hematologic cancer	0.000696	0.000879	CcSEcCtD
Phendimetrazine—Anorexia—Betamethasone—hematologic cancer	0.000696	0.000879	CcSEcCtD
Phendimetrazine—Sweating—Doxorubicin—hematologic cancer	0.000692	0.000873	CcSEcCtD
Phendimetrazine—Headache—Vincristine—hematologic cancer	0.000686	0.000866	CcSEcCtD
Phendimetrazine—Nausea—Carmustine—hematologic cancer	0.000682	0.00086	CcSEcCtD
Phendimetrazine—Nausea—Alitretinoin—hematologic cancer	0.000675	0.000852	CcSEcCtD
Phendimetrazine—Headache—Irinotecan—hematologic cancer	0.000668	0.000844	CcSEcCtD
Phendimetrazine—Headache—Mitoxantrone—hematologic cancer	0.000668	0.000844	CcSEcCtD
Phendimetrazine—Nausea—Ifosfamide—hematologic cancer	0.000667	0.000842	CcSEcCtD
Phendimetrazine—Diarrhoea—Cisplatin—hematologic cancer	0.000663	0.000836	CcSEcCtD
Phendimetrazine—Insomnia—Dexamethasone—hematologic cancer	0.000661	0.000834	CcSEcCtD
Phendimetrazine—Insomnia—Betamethasone—hematologic cancer	0.000661	0.000834	CcSEcCtD
Phendimetrazine—Headache—Gemcitabine—hematologic cancer	0.000651	0.000822	CcSEcCtD
Phendimetrazine—Nausea—Vincristine—hematologic cancer	0.000651	0.000821	CcSEcCtD
Phendimetrazine—Flushing—Epirubicin—hematologic cancer	0.00065	0.00082	CcSEcCtD
Phendimetrazine—Decreased appetite—Betamethasone—hematologic cancer	0.000635	0.000801	CcSEcCtD
Phendimetrazine—Decreased appetite—Dexamethasone—hematologic cancer	0.000635	0.000801	CcSEcCtD
Phendimetrazine—Nausea—Irinotecan—hematologic cancer	0.000634	0.0008	CcSEcCtD
Phendimetrazine—Nausea—Mitoxantrone—hematologic cancer	0.000634	0.0008	CcSEcCtD
Phendimetrazine—Tachycardia—Prednisone—hematologic cancer	0.000621	0.000783	CcSEcCtD
Phendimetrazine—Nausea—Gemcitabine—hematologic cancer	0.000617	0.000779	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Prednisone—hematologic cancer	0.000615	0.000776	CcSEcCtD
Phendimetrazine—Vision blurred—Methotrexate—hematologic cancer	0.000614	0.000775	CcSEcCtD
Phendimetrazine—Diarrhoea—Etoposide—hematologic cancer	0.000607	0.000766	CcSEcCtD
Phendimetrazine—Anorexia—Prednisone—hematologic cancer	0.000606	0.000765	CcSEcCtD
Phendimetrazine—Flushing—Doxorubicin—hematologic cancer	0.000601	0.000759	CcSEcCtD
Phendimetrazine—Dizziness—Etoposide—hematologic cancer	0.000587	0.000741	CcSEcCtD
Phendimetrazine—Dizziness—Prednisolone—hematologic cancer	0.000579	0.000731	CcSEcCtD
Phendimetrazine—Abdominal pain—Dexamethasone—hematologic cancer	0.000577	0.000729	CcSEcCtD
Phendimetrazine—Abdominal pain—Betamethasone—hematologic cancer	0.000577	0.000729	CcSEcCtD
Phendimetrazine—Nausea—Cisplatin—hematologic cancer	0.000575	0.000726	CcSEcCtD
Phendimetrazine—Insomnia—Prednisone—hematologic cancer	0.000575	0.000726	CcSEcCtD
Phendimetrazine—Vision blurred—Epirubicin—hematologic cancer	0.000574	0.000725	CcSEcCtD
Phendimetrazine—Agitation—Epirubicin—hematologic cancer	0.00056	0.000707	CcSEcCtD
Phendimetrazine—Headache—Etoposide—hematologic cancer	0.000556	0.000702	CcSEcCtD
Phendimetrazine—Decreased appetite—Prednisone—hematologic cancer	0.000553	0.000698	CcSEcCtD
Phendimetrazine—Headache—Prednisolone—hematologic cancer	0.000548	0.000692	CcSEcCtD
Phendimetrazine—Constipation—Prednisone—hematologic cancer	0.000544	0.000686	CcSEcCtD
Phendimetrazine—Palpitations—Epirubicin—hematologic cancer	0.000539	0.00068	CcSEcCtD
Phendimetrazine—Dizziness—Triamcinolone—hematologic cancer	0.000532	0.000672	CcSEcCtD
Phendimetrazine—Vision blurred—Doxorubicin—hematologic cancer	0.000532	0.000671	CcSEcCtD
Phendimetrazine—Nausea—Etoposide—hematologic cancer	0.000527	0.000665	CcSEcCtD
Phendimetrazine—Nausea—Prednisolone—hematologic cancer	0.00052	0.000656	CcSEcCtD
Phendimetrazine—Agitation—Doxorubicin—hematologic cancer	0.000518	0.000654	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Methotrexate—hematologic cancer	0.000514	0.000649	CcSEcCtD
Phendimetrazine—Anorexia—Methotrexate—hematologic cancer	0.000507	0.000639	CcSEcCtD
Phendimetrazine—Headache—Triamcinolone—hematologic cancer	0.000504	0.000636	CcSEcCtD
Phendimetrazine—Abdominal pain—Prednisone—hematologic cancer	0.000503	0.000635	CcSEcCtD
Phendimetrazine—Diarrhoea—Dexamethasone—hematologic cancer	0.0005	0.000631	CcSEcCtD
Phendimetrazine—Diarrhoea—Betamethasone—hematologic cancer	0.0005	0.000631	CcSEcCtD
Phendimetrazine—Palpitations—Doxorubicin—hematologic cancer	0.000498	0.000629	CcSEcCtD
Phendimetrazine—Tachycardia—Epirubicin—hematologic cancer	0.000486	0.000613	CcSEcCtD
Phendimetrazine—Dizziness—Dexamethasone—hematologic cancer	0.000483	0.00061	CcSEcCtD
Phendimetrazine—Dizziness—Betamethasone—hematologic cancer	0.000483	0.00061	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Epirubicin—hematologic cancer	0.000481	0.000607	CcSEcCtD
Phendimetrazine—Insomnia—Methotrexate—hematologic cancer	0.000481	0.000607	CcSEcCtD
Phendimetrazine—Nausea—Triamcinolone—hematologic cancer	0.000478	0.000603	CcSEcCtD
Phendimetrazine—Anorexia—Epirubicin—hematologic cancer	0.000474	0.000598	CcSEcCtD
Phendimetrazine—Decreased appetite—Methotrexate—hematologic cancer	0.000462	0.000583	CcSEcCtD
Phendimetrazine—Headache—Dexamethasone—hematologic cancer	0.000458	0.000577	CcSEcCtD
Phendimetrazine—Headache—Betamethasone—hematologic cancer	0.000458	0.000577	CcSEcCtD
Phendimetrazine—Insomnia—Epirubicin—hematologic cancer	0.00045	0.000568	CcSEcCtD
Phendimetrazine—Tachycardia—Doxorubicin—hematologic cancer	0.000449	0.000567	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000445	0.000562	CcSEcCtD
Phendimetrazine—Anorexia—Doxorubicin—hematologic cancer	0.000439	0.000554	CcSEcCtD
Phendimetrazine—Diarrhoea—Prednisone—hematologic cancer	0.000435	0.000549	CcSEcCtD
Phendimetrazine—Nausea—Dexamethasone—hematologic cancer	0.000434	0.000548	CcSEcCtD
Phendimetrazine—Nausea—Betamethasone—hematologic cancer	0.000434	0.000548	CcSEcCtD
Phendimetrazine—Decreased appetite—Epirubicin—hematologic cancer	0.000432	0.000546	CcSEcCtD
Phendimetrazine—Constipation—Epirubicin—hematologic cancer	0.000425	0.000537	CcSEcCtD
Phendimetrazine—Dizziness—Prednisone—hematologic cancer	0.000421	0.000531	CcSEcCtD
Phendimetrazine—Abdominal pain—Methotrexate—hematologic cancer	0.00042	0.00053	CcSEcCtD
Phendimetrazine—Insomnia—Doxorubicin—hematologic cancer	0.000416	0.000525	CcSEcCtD
Phendimetrazine—Decreased appetite—Doxorubicin—hematologic cancer	0.0004	0.000505	CcSEcCtD
Phendimetrazine—Headache—Prednisone—hematologic cancer	0.000398	0.000503	CcSEcCtD
Phendimetrazine—Constipation—Doxorubicin—hematologic cancer	0.000394	0.000497	CcSEcCtD
Phendimetrazine—Abdominal pain—Epirubicin—hematologic cancer	0.000393	0.000496	CcSEcCtD
Phendimetrazine—Nausea—Prednisone—hematologic cancer	0.000378	0.000477	CcSEcCtD
Phendimetrazine—Abdominal pain—Doxorubicin—hematologic cancer	0.000364	0.000459	CcSEcCtD
Phendimetrazine—Diarrhoea—Methotrexate—hematologic cancer	0.000364	0.000459	CcSEcCtD
Phendimetrazine—Dizziness—Methotrexate—hematologic cancer	0.000352	0.000444	CcSEcCtD
Phendimetrazine—Diarrhoea—Epirubicin—hematologic cancer	0.00034	0.00043	CcSEcCtD
Phendimetrazine—Headache—Methotrexate—hematologic cancer	0.000333	0.00042	CcSEcCtD
Phendimetrazine—Dizziness—Epirubicin—hematologic cancer	0.000329	0.000415	CcSEcCtD
Phendimetrazine—Nausea—Methotrexate—hematologic cancer	0.000316	0.000398	CcSEcCtD
Phendimetrazine—Diarrhoea—Doxorubicin—hematologic cancer	0.000315	0.000397	CcSEcCtD
Phendimetrazine—Headache—Epirubicin—hematologic cancer	0.000312	0.000393	CcSEcCtD
Phendimetrazine—Dizziness—Doxorubicin—hematologic cancer	0.000304	0.000384	CcSEcCtD
Phendimetrazine—Nausea—Epirubicin—hematologic cancer	0.000295	0.000373	CcSEcCtD
Phendimetrazine—Headache—Doxorubicin—hematologic cancer	0.000288	0.000364	CcSEcCtD
Phendimetrazine—Nausea—Doxorubicin—hematologic cancer	0.000273	0.000345	CcSEcCtD
Phendimetrazine—ADRA1A—GPCR downstream signaling—CSF2—hematologic cancer	6.66e-05	0.000321	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—JAK1—hematologic cancer	6.57e-05	0.000316	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PRKCG—hematologic cancer	6.57e-05	0.000316	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SH2B3—hematologic cancer	6.54e-05	0.000315	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SMARCA4—hematologic cancer	6.54e-05	0.000315	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDE4B—hematologic cancer	6.52e-05	0.000314	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CNR2—hematologic cancer	6.52e-05	0.000314	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GZMB—hematologic cancer	6.5e-05	0.000313	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hematologic cancer	6.49e-05	0.000312	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGF19—hematologic cancer	6.46e-05	0.000311	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PRKCG—hematologic cancer	6.42e-05	0.000309	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—JAK1—hematologic cancer	6.42e-05	0.000309	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—RAC2—hematologic cancer	6.41e-05	0.000309	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—DKK1—hematologic cancer	6.36e-05	0.000306	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CTNNA1—hematologic cancer	6.35e-05	0.000306	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—STAT5B—hematologic cancer	6.31e-05	0.000304	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EIF4EBP1—hematologic cancer	6.31e-05	0.000304	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCL3—hematologic cancer	6.31e-05	0.000304	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HSPB1—hematologic cancer	6.31e-05	0.000304	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SDC1—hematologic cancer	6.24e-05	0.0003	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTHLH—hematologic cancer	6.24e-05	0.0003	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL2RA—hematologic cancer	6.13e-05	0.000295	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ADCY7—hematologic cancer	6.13e-05	0.000295	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTGER4—hematologic cancer	6.07e-05	0.000292	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CSF2—hematologic cancer	6.04e-05	0.000291	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LCK—hematologic cancer	6.04e-05	0.000291	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—IL2RA—hematologic cancer	6e-05	0.000289	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—XIAP—hematologic cancer	5.96e-05	0.000287	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—H3F3A—hematologic cancer	5.92e-05	0.000285	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—JAK1—hematologic cancer	5.83e-05	0.000281	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PRKCG—hematologic cancer	5.83e-05	0.000281	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SMARCA4—hematologic cancer	5.81e-05	0.00028	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SH2B3—hematologic cancer	5.81e-05	0.00028	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GZMB—hematologic cancer	5.77e-05	0.000278	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PRKCZ—hematologic cancer	5.76e-05	0.000277	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CTNNA1—hematologic cancer	5.64e-05	0.000271	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CG—hematologic cancer	5.63e-05	0.000271	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EIF4EBP1—hematologic cancer	5.6e-05	0.00027	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCL3—hematologic cancer	5.6e-05	0.00027	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HSPB1—hematologic cancer	5.6e-05	0.00027	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PARP1—hematologic cancer	5.56e-05	0.000268	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SDC1—hematologic cancer	5.54e-05	0.000267	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTHLH—hematologic cancer	5.54e-05	0.000267	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FBXW7—hematologic cancer	5.47e-05	0.000263	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL2RA—hematologic cancer	5.45e-05	0.000262	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTGER4—hematologic cancer	5.39e-05	0.00026	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LCK—hematologic cancer	5.37e-05	0.000258	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HDAC2—hematologic cancer	5.36e-05	0.000258	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CXCR4—hematologic cancer	5.36e-05	0.000258	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—H3F3A—hematologic cancer	5.26e-05	0.000253	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CBL—hematologic cancer	5.23e-05	0.000252	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL3—hematologic cancer	5.17e-05	0.000249	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PRKCZ—hematologic cancer	5.11e-05	0.000246	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CG—hematologic cancer	5.11e-05	0.000246	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTPN1—hematologic cancer	5.09e-05	0.000245	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PTPN11—hematologic cancer	5.02e-05	0.000242	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—RASGRP1—hematologic cancer	5e-05	0.000241	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CG—hematologic cancer	5e-05	0.000241	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SYK—hematologic cancer	4.99e-05	0.00024	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HSP90AA1—hematologic cancer	4.99e-05	0.00024	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CD—hematologic cancer	4.95e-05	0.000238	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PARP1—hematologic cancer	4.94e-05	0.000238	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CREB1—hematologic cancer	4.86e-05	0.000234	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FBXW7—hematologic cancer	4.86e-05	0.000234	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—STAT1—hematologic cancer	4.81e-05	0.000232	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HDAC2—hematologic cancer	4.76e-05	0.000229	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CXCR4—hematologic cancer	4.76e-05	0.000229	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—CCL2—hematologic cancer	4.76e-05	0.000229	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL6R—hematologic cancer	4.75e-05	0.000229	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3R1—hematologic cancer	4.67e-05	0.000225	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CBL—hematologic cancer	4.64e-05	0.000224	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL3—hematologic cancer	4.59e-05	0.000221	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—JAK2—hematologic cancer	4.54e-05	0.000219	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CG—hematologic cancer	4.54e-05	0.000219	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—MAP2K1—hematologic cancer	4.52e-05	0.000218	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTPN1—hematologic cancer	4.52e-05	0.000218	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GRB2—hematologic cancer	4.5e-05	0.000217	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CD—hematologic cancer	4.49e-05	0.000216	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PDGFA—hematologic cancer	4.49e-05	0.000216	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PTPN11—hematologic cancer	4.46e-05	0.000215	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—RASGRP1—hematologic cancer	4.44e-05	0.000214	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HSP90AA1—hematologic cancer	4.43e-05	0.000213	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SYK—hematologic cancer	4.43e-05	0.000213	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KITLG—hematologic cancer	4.42e-05	0.000213	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CD—hematologic cancer	4.39e-05	0.000212	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—STAT5A—hematologic cancer	4.32e-05	0.000208	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CREB1—hematologic cancer	4.32e-05	0.000208	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CB—hematologic cancer	4.31e-05	0.000208	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CDKN2B—hematologic cancer	4.29e-05	0.000206	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—STAT1—hematologic cancer	4.27e-05	0.000206	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3R1—hematologic cancer	4.24e-05	0.000204	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—CCL2—hematologic cancer	4.23e-05	0.000204	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL6R—hematologic cancer	4.21e-05	0.000203	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3R1—hematologic cancer	4.15e-05	0.0002	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CD86—hematologic cancer	4.15e-05	0.0002	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—JAK2—hematologic cancer	4.12e-05	0.000199	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HES1—hematologic cancer	4.09e-05	0.000197	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NCOR1—hematologic cancer	4.07e-05	0.000196	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—JAK2—hematologic cancer	4.03e-05	0.000194	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CSF2—hematologic cancer	4.02e-05	0.000194	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGF1—hematologic cancer	4.02e-05	0.000194	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—MAP2K1—hematologic cancer	4.02e-05	0.000193	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GRB2—hematologic cancer	4e-05	0.000192	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CD—hematologic cancer	3.99e-05	0.000192	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDGFA—hematologic cancer	3.99e-05	0.000192	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FOXO1—hematologic cancer	3.96e-05	0.000191	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—IL2—hematologic cancer	3.96e-05	0.000191	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PDGFRB—hematologic cancer	3.95e-05	0.00019	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KITLG—hematologic cancer	3.93e-05	0.000189	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CB—hematologic cancer	3.92e-05	0.000189	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PDGFRA—hematologic cancer	3.89e-05	0.000187	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PRKCG—hematologic cancer	3.88e-05	0.000187	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—JAK1—hematologic cancer	3.88e-05	0.000187	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—STAT5A—hematologic cancer	3.84e-05	0.000185	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CB—hematologic cancer	3.83e-05	0.000184	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CDKN2B—hematologic cancer	3.81e-05	0.000183	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3R1—hematologic cancer	3.77e-05	0.000181	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CD86—hematologic cancer	3.68e-05	0.000177	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—JAK2—hematologic cancer	3.66e-05	0.000176	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HES1—hematologic cancer	3.63e-05	0.000175	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL2RA—hematologic cancer	3.62e-05	0.000175	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NCOR1—hematologic cancer	3.61e-05	0.000174	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL2—hematologic cancer	3.6e-05	0.000173	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TERT—hematologic cancer	3.58e-05	0.000173	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGF1—hematologic cancer	3.57e-05	0.000172	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CSF2—hematologic cancer	3.57e-05	0.000172	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FOXO1—hematologic cancer	3.52e-05	0.000169	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—IL2—hematologic cancer	3.52e-05	0.000169	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDGFRB—hematologic cancer	3.51e-05	0.000169	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PDGFB—hematologic cancer	3.5e-05	0.000168	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CB—hematologic cancer	3.48e-05	0.000167	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDGFRA—hematologic cancer	3.46e-05	0.000167	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—JAK1—hematologic cancer	3.45e-05	0.000166	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PRKCG—hematologic cancer	3.45e-05	0.000166	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TSC2—hematologic cancer	3.42e-05	0.000165	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGFR3—hematologic cancer	3.29e-05	0.000158	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAPK14—hematologic cancer	3.26e-05	0.000157	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL2RA—hematologic cancer	3.22e-05	0.000155	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL2—hematologic cancer	3.19e-05	0.000154	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ESR1—hematologic cancer	3.19e-05	0.000154	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TERT—hematologic cancer	3.18e-05	0.000153	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FN1—hematologic cancer	3.15e-05	0.000152	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—BAD—hematologic cancer	3.12e-05	0.00015	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NFKBIA—hematologic cancer	3.12e-05	0.00015	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PDGFB—hematologic cancer	3.11e-05	0.00015	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NOTCH1—hematologic cancer	3.09e-05	0.000149	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TSC2—hematologic cancer	3.04e-05	0.000146	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CD80—hematologic cancer	3.02e-05	0.000146	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CG—hematologic cancer	3.02e-05	0.000145	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KIT—hematologic cancer	3.02e-05	0.000145	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—NRAS—hematologic cancer	3.02e-05	0.000145	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTPN11—hematologic cancer	2.97e-05	0.000143	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGFR3—hematologic cancer	2.92e-05	0.000141	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAPK14—hematologic cancer	2.89e-05	0.000139	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—MAPK3—hematologic cancer	2.89e-05	0.000139	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CREB1—hematologic cancer	2.87e-05	0.000138	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—BRAF—hematologic cancer	2.84e-05	0.000137	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ESR1—hematologic cancer	2.84e-05	0.000137	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCL2—hematologic cancer	2.81e-05	0.000135	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL6R—hematologic cancer	2.8e-05	0.000135	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FN1—hematologic cancer	2.8e-05	0.000135	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CREBBP—hematologic cancer	2.8e-05	0.000135	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—BAD—hematologic cancer	2.77e-05	0.000133	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NFKBIA—hematologic cancer	2.77e-05	0.000133	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NOTCH1—hematologic cancer	2.74e-05	0.000132	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CD80—hematologic cancer	2.69e-05	0.000129	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CG—hematologic cancer	2.68e-05	0.000129	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KIT—hematologic cancer	2.68e-05	0.000129	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—NRAS—hematologic cancer	2.68e-05	0.000129	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAP2K1—hematologic cancer	2.67e-05	0.000129	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CD—hematologic cancer	2.65e-05	0.000128	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTPN11—hematologic cancer	2.63e-05	0.000127	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CA—hematologic cancer	2.63e-05	0.000127	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—KRAS—hematologic cancer	2.6e-05	0.000125	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—MAPK3—hematologic cancer	2.57e-05	0.000124	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CREB1—hematologic cancer	2.55e-05	0.000123	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FGF2—hematologic cancer	2.54e-05	0.000122	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—BRAF—hematologic cancer	2.52e-05	0.000121	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3R1—hematologic cancer	2.51e-05	0.000121	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCL2—hematologic cancer	2.5e-05	0.00012	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL6R—hematologic cancer	2.49e-05	0.00012	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CREBBP—hematologic cancer	2.49e-05	0.00012	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—JAK2—hematologic cancer	2.44e-05	0.000117	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CA—hematologic cancer	2.39e-05	0.000115	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MDM2—hematologic cancer	2.38e-05	0.000114	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAP2K1—hematologic cancer	2.37e-05	0.000114	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CD—hematologic cancer	2.36e-05	0.000114	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CA—hematologic cancer	2.33e-05	0.000112	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MTOR—hematologic cancer	2.31e-05	0.000111	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CB—hematologic cancer	2.31e-05	0.000111	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	2.31e-05	0.000111	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	2.26e-05	0.000109	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	2.23e-05	0.000107	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—HRAS—hematologic cancer	2.21e-05	0.000106	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CDKN1B—hematologic cancer	2.17e-05	0.000105	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	2.16e-05	0.000104	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—AKT1—hematologic cancer	2.15e-05	0.000103	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CASP3—hematologic cancer	2.13e-05	0.000102	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL2—hematologic cancer	2.12e-05	0.000102	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	2.12e-05	0.000102	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL6—hematologic cancer	2.11e-05	0.000102	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	2.11e-05	0.000102	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCND1—hematologic cancer	2.07e-05	9.97e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—JUN—hematologic cancer	2.07e-05	9.95e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	2.05e-05	9.89e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	2.05e-05	9.89e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CDKN1A—hematologic cancer	2e-05	9.65e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTEN—hematologic cancer	2e-05	9.63e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	1.96e-05	9.45e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAPK8—hematologic cancer	1.96e-05	9.42e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—AKT1—hematologic cancer	1.95e-05	9.39e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	1.93e-05	9.29e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	1.91e-05	9.19e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EP300—hematologic cancer	1.91e-05	9.18e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	1.89e-05	9.1e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	1.89e-05	9.09e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	1.88e-05	9.04e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SRC—hematologic cancer	1.85e-05	8.93e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	1.84e-05	8.86e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	1.84e-05	8.84e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	1.81e-05	8.69e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	1.79e-05	8.61e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	1.78e-05	8.59e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	1.78e-05	8.57e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	1.78e-05	8.55e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	1.74e-05	8.36e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	1.73e-05	8.34e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	1.71e-05	8.22e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	1.69e-05	8.15e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	1.66e-05	8e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	1.66e-05	7.98e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.65e-05	7.93e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.6e-05	7.72e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.59e-05	7.65e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.58e-05	7.63e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	1.53e-05	7.39e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	1.52e-05	7.31e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.48e-05	7.11e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.47e-05	7.09e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	1.41e-05	6.79e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	1.36e-05	6.57e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	1.36e-05	6.57e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	1.3e-05	6.28e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	1.25e-05	6.03e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	1.25e-05	6.01e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	1.21e-05	5.84e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	1.16e-05	5.58e-05	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	1.15e-05	5.55e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	1.11e-05	5.34e-05	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	1.02e-05	4.93e-05	CbGpPWpGaD
